Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126595361 | 12659536 | 1 | I | 20160220 | 0 | 20160816 | 20160816 | DIR | 20.05 | YR | M | N | 95.30000 | KG | 20160815 | N | MD | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126595361 | 12659536 | 1 | PS | ONCASPAR | PEGASPARGASE | 1 | 0 | 5025 | IU | ||||||||||
126595361 | 12659536 | 2 | SS | MITOXANTRONE HYDROCHLORIDE. | MITOXANTRONE HYDROCHLORIDE | 1 | 0 | 40.2 | MG | ||||||||||
126595361 | 12659536 | 3 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | 0 | 2 | MG |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126595361 | 12659536 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126595361 | 12659536 | Bacteraemia | |
126595361 | 12659536 | Device related sepsis | |
126595361 | 12659536 | Febrile neutropenia | |
126595361 | 12659536 | Lactic acidosis | |
126595361 | 12659536 | Pancytopenia | |
126595361 | 12659536 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
126595361 | 12659536 | HP |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126595361 | 12659536 | 1 | 20160214 | 0 | ||
126595361 | 12659536 | 2 | 20160213 | 0 | ||
126595361 | 12659536 | 3 | 20160212 | 0 |